Playback speed
10 seconds
Clinical Activity of MCLA-158 (Petosemtamab), an IgG1 Bispecific Antibody Targeting EGFR and LGR5, in Advanced HNSCC
By
AACR 2023 Conference Coverage
FEATURING
Ezra Cohen
By
AACR 2023 Conference Coverage
FEATURING
Ezra Cohen
0 views
May 18, 2023
Comments 0
Login to view comments.
Click here to Login